NF-κB Signaling, Liver Disease and Hepatoprotective Agents

Oncogene - United Kingdom
doi 10.1038/onc.2008.300
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Inhibition of CCL19 Benefits Non‑alcoholic Fatty Liver Disease by Inhibiting TLR4/NF‑κB‑p65 Signaling

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2018English

Ubiquitin in NF-κB Signaling

Chemical Reviews
Chemistry
2009English

Molecular Basis of NF-κB Signaling

Annual Review of Biophysics
BiochemistryBioengineeringCell BiologyStructural BiologyBiophysics
2013English

Non-Canonical NF-κB Signaling Pathway

Cell Research
Cell BiologyMolecular Biology
2010English

Curcumin Effectively Inhibits Oncogenic NF-κB Signaling and Restrains Stemness Features in Liver Cancer

Journal of Hepatology
Hepatology
2015English

NF-κB Signaling Regulates Physiological and Pathological Chondrogenesis

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2019English

NF-κB Signaling Pathway and Free Radical Impact.

Acta Biochimica Polonica
BiochemistryGeneticsMolecular Biology
2012English

NF-κB Signaling Pathway, Inflammation and Colorectal Cancer

Cellular and Molecular Immunology
Infectious DiseasesMedicineAllergyImmunology
2009English

Apoptotic Cells Induce NF-κB and Inflammasome Negative Signaling

PLoS ONE
Multidisciplinary
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy